Ranolazine (Monograph) Brand name:Ranexa Drug class:Cardiac Drugs, Miscellaneous VA class:CV250 Chemical name:N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide Molecular formula:C24H33N3O4 CAS number:95636-55-5 ...
Ranolazine (Ranexa; Cardiovascular Therapeutics) was approved by the US FDA for the treatment of chronic angina in January 2006. It is the first drug in a new class for treating this condition to be approved in the United States in more than 20 years.Abrams...
General Pronunciation: ra-nole-a-zeen To hear audio pronunciation of this topic, purchase a subscription or log in. Trade Name(s) Corzyna Ranexa Ther. Class. antianginals There's more to see -- the rest of this topic is available only to subscribers. ...
there has been some concern that it might have proarrhythmic effects, and its indication has therefore been limited to second-line therapy in patients who continue to experience angina despite treatment with another class of antianginal medication. Following the reassuring...
(see sections # and #). Mild to moderate renal impairment (creatinine clearance # ml/min) (see sections #, #, and #). Elderly (see sections #, #, and #). Patients with low weight (# kg) (see sections #, #, and #). Patients with moderate to severe CHF (NYHA Class # IV) (...
General Pronunciation: ra-nole-a-zeen To hear audio pronunciation of this topic, purchase a subscription or log in. Trade Name(s) Corzyna Ranexa Ther. Class. antianginals There's more to see -- the rest of this topic is available only to subscribers....
Ranolazine is a first-in-class piperazine derivative that inhibits the late inward sodium current in cardiac cells and is considered an effective and safe option for treating patients with CSA. As with any first-in-class agent, it is important for the practitioner to be familiar with the ...
In this brief, the finite-horizon H∞ fault estimation problem is investigated for a class of uncertain linear discrete time-varying systems with known inp... S Bo,SX Ding,Z Wang - 《IEEE Transactions on Circuits & Systems II Analog & Digital Signal Processing》 被引量: 25发表: 2013年 Th...
Jerling, Marcus (Bromma, SE) Wolff, Andrew (San Francisco, CA, US) Application Number: 12/052381 Publication Date: 09/25/2008 Filing Date: 03/20/2008 Export Citation: Click for automatic bibliography generation Primary Class: 424/468
摘要: Ranolazine (Ranexa; Cardiovascular Therapeutics) was approved by the US FDA for the treatment of chronic angina in January 2006. It is the first drug in a new class for treating this condition to be approved in the United States in more than 20 years....